SBIROpen

Broadening Availability of Regimens for K-9s (BARK) - Open Topic

Solicitation ID26.BZ
Agency
DOD
DARPA
Deadline
Jun 3, 2026
10 days left
Posted Date
Apr 13, 2026
Classification
SBIR
Phase: BOTH

SBIR Opportunity Analysis

DARPA, within the Department of Defense, is seeking SBIR proposals for the BARK open topic to develop medical products that are interoperable across humans and military working dogs and reduce the logistical burden of separate human and canine medical kits. The work covers cross-species compatible donor plasma filters, universal synthetic plasma, physiological monitoring sensors, rapidly adjustable devices such as splints and tourniquets, interoperable medical countermeasures, and dosing delivery mechanisms that can support both patient sets. Phase I is limited to in vitro or in silico feasibility work and preliminary prototype design with no human or animal subject research, while Phase II is intended to advance a demonstrative prototype through fabrication, preclinical testing, user testing, and regulatory and commercialization planning. An initial white paper is required before full proposal consideration, and the application deadline is June 3, 2026 at 4:00 PM UTC.

SBIR Documents

1 Files
1776211344410.pdf
PDF76 KBMay 11, 2026
AI Summary
The Broadening Availability of Regimens for K-9s (BARK) initiative, DPA26BZ01-NP001, seeks to develop medical products interoperable for both human warfighters and military working dogs (MWDs). This Defense Advanced Research Projects Agency (DARPA) solicitation aims to reduce logistical burdens and improve medical care by creating universal medical technologies, especially for acute and tactical care. Technologies of interest include cross-species compatible filters for donor plasma, universal synthetic plasma, physiological monitoring sensors, rapidly adjustable medical devices (e.g., splints, tourniquets), interoperable medical countermeasures, and modulated dosing delivery mechanisms. The project discourages new drug discovery and research that merely tests existing products. Phase I focuses on in vitro or in silico technical feasibility and preliminary prototype design, prohibiting human or animal subject research. Phase II involves prototype fabrication, demonstration, testing in preclinical settings, and user testing. Proposed technologies must be safe and effective in both humans and canines, demonstrating performance substantially equivalent or superior to existing human-approved options. Dual-use applications for these technologies extend to military and civilian medical emergencies, veterinary medicine, and various working dog sectors. Submissions require an initial white paper detailing the proposed concept, employment, path to market, and scalability.

Related SBIR/STTR Opportunities

Opportunity Snapshot

Source SystemOfficial Link
Program Type
SBIR - BOTH
Agency
DOD / DARPA

Key Dates

Release DateApr 13, 2026
Open DateMay 6, 2026
Application DueJun 3, 2026
Close DateJun 3, 2026